⌘K

Login Start Free

Home/Filings/4/0001144204-19-017413

4//SEC Filing

NASH DAVID 4

Accession 0001144204-19-017413

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:02 PM ET

Size

7.0 KB

Accession

0001144204-19-017413

Insider Transaction Report

Form 4

Period: 2019-03-28

ANI PHARMACEUTICALS INCANIP

Director

Transactions

Award
Common Stock
2019-03-28+1,991→ 3,791 total
Award
Stock Options
2019-03-28+2,409→ 2,409 total
Exercise: $66.39Exp: 2029-03-27→ Common Stock (2,409 underlying)

Footnotes (1)

[F1]The restricted stock and stock option vest on March 28, 2020.

Documents

1 file

4
tv517662_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001251968

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 4:02 PM ET
Size: 7.0 KB

View on SEC.gov